Development of an enzyme-linked immunosorbent assay analytical platform for refolding yield determination of recombinant hepatitis B virus X (HBx) protein

Analytical Biochemistry

Volumn 418, Issue 1, 2011, Pages 155-157

  Basu, Anindya ^a   Leong, Susanna Su Jan ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

ELISA; Hepatitis B; Hepatitis B virus X (HBx) protein; Refolding yield; Soluble yield

Indexed keywords

VIRUSES;

ELISA; HEPATITIS B; HEPATITIS B VIRUS; REFOLDING; SOLUBLE YIELD;

RECOMBINANT PROTEINS;

GLUTATHIONE; GLUTATHIONE TRANSFERASE; HEPATITIS B VIRUS X PROTEIN; MALEIMIDE; PROTEIN P53;

ARTICLE; BIOLOGICAL ACTIVITY; BIOPROCESS; CALIBRATION; CELL ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; LIVER CANCER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN REFOLDING; REDUCTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCALE UP;

HEPATITIS B VIRUS;

EID: 80052261824     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.07.014     Document Type: Article

References (21)

1. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J. Viral Hepatitis 11 2004 97 107 (Pubitemid 38365759)
2. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int. J. Cancer 80 1999 1990 827 841
3. A.S. Lok Navigating the maze of hepatitis B treatments Gastroenterology 132 2007 1586 1594 (Pubitemid 46627589)
4. M. Nassal New insights into HBV replication: new opportunities for improved therapies Future Virol. 4 2009 55 70
5. S. Benhenda, D. Cougot, M.A. Buendia, and C. Neuveut Chapter 4 hepatitis B virus X protein. Molecular functions and its role in virus life cycle and pathogenesis Adv. Cancer Res. 103 2009 75 109
6. L.L. David, H. Nguyen, and Jianming Hu Hepatitis B virus-cell interactions and pathogenesis J. Cell. Physiol. 216 2008 289 294 (Pubitemid 351898452)
7. H. Tang, N. Oishi, S. Kaneko, and S. Murakami Molecular functions and biological roles of hepatitis B virus x protein Cancer Sci. 97 2006 977 983 (Pubitemid 44322542)
8. S. Mandal, M. Moudgil, and S.K. Mandal Rational drug design Eur. J. Pharmacol. 625 2009 90 100
9. A. Gupta, T.K. Mal, N. Jayasuryan, and V.S. Chauhan Assignment of disulphide bonds in the X protein (HBx) of hepatitis B virus Biochem. Biophys. Res. Commun. 212 1995 919 924
10. I. Marczinovits, C. Somogyi, A. Patthy, P. Németh, and J. Molnár An alternative purification protocol for producing hepatitis B virus X antigen on a preparative scale in Escherichia coli J. Biotechnol. 56 1997 81 88 (Pubitemid 27391876)
11. G.Y. Hwang, C.Y. Lin, L.M. Huang, Y.H. Wang, J.C. Wang, C.T. Hsu, S.S. Yang, and C.C. Wu Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma J. Clin. Microbiol. 41 2003 5598 5603
12. S.M. Zhang, D.C. Sun, S. Lou, X.C. Bo, Z. Lu, X.H. Qian, and S.Q. Wang HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70 Arch. Virol. 150 2005 1579 1590 (Pubitemid 41187180)
13. D. Liu, L. Zou, W. Li, L. Wang, and Y. Wu High-level expression and large-scale preparation of soluble HBx antigen from Escherichia coli Biotechnol. Appl. Biochem. 54 2009 141 147
14. E. Rui, P.R. De Moura, K. de Almeida Gonalves, and J. Kobarg Expression and spectroscopic analysis of a mutant hepatitis B virus onco-protein HBx without cysteine residues J. Virol. Methods 126 2005 65 74 (Pubitemid 40558744)
15. M.C. Kew Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma J. Gastroenterol. Hepatol. 26 2011 144 152
16. M.A. Feitelson, M. Zhu, L.X. Duan, and W.T. London Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma Oncogene 8 1993 1109 1117 (Pubitemid 23129832)
17. P.R. de Moura, E. Rui, K. de Almeida Gonalves, and J. Kobarg The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53 Virus Res. 108 2005 121 131 (Pubitemid 40170340)
18. Y. Lin, H. Tang, T. Nomura, D. Dorjsuren, N. Hayashi, W. Wei, T. Ohta, R. Roeder, and S. Murakami The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators J. Biol. Chem. 273 1998 27097 27103 (Pubitemid 28500415)
19. R. Truant, J. Antunovic, J. Greenblatt, C. Prives, and J.A. Cromlish Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation J. Virol. 69 1995 1851 1859
20. A. Basu, W. Chen, and S. Leong A rational design for hepatitis B virus X protein refolding and bioprocess development guided by second virial coefficient studies Appl. Microbiol. Biotechnol. 90 2011 181 191
21. G.T. Hermanson Bioconjugate Techniques 2008 Elsevier Academic Press Amsterdam